rs727504379
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_005159.5(ACTC1):c.866T>C(p.Ile289Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_005159.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ACTC1 | NM_005159.5 | c.866T>C | p.Ile289Thr | missense_variant | Exon 6 of 7 | ENST00000290378.6 | NP_005150.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ACTC1 | ENST00000290378.6 | c.866T>C | p.Ile289Thr | missense_variant | Exon 6 of 7 | 1 | NM_005159.5 | ENSP00000290378.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This missense change is denoted p.Ile289Thr (aka I289T) at the protein level, and c.866 T>C at the cDNA level. The Ile289Thr variant in the ACTC1 gene has not been reported previously as a disease-causing mutation or as a benign polymorphism, to our knowledge. Ile289Thr results in a non-conservative amino acid substitution of a non-polar Isoleucine with a neutral, polar Threonine at a position that is class conserved throughout evolution. In silico analysis predicts Ile289Thr is disease-causing. A mutation in a nearby codon (Ala297Ser) has been reported in association with cardiomyopathy, supporting the functional importance of this region of the protein. Furthermore, Ile289Thr was not detected in up to 200 control alleles from individuals of Caucasian ancestry tested at GeneDx, indicating it is not a common benign variant in this population. In summary, with the clinical and molecular information available at this time, we cannot unequivocally determine the clinical significance of the Ile289Thr variant in the ACTC1 gene though evidence suggests it may be disease-causing. The variant is found in DCM panel(s). -
Primary dilated cardiomyopathy Pathogenic:1
The p.Ile289Thr variant in ACTC1 has been identified in 3 individuals with dilated cardiomyopathy (DCM), 2 of whom had additional cardiomyopathy features (1 with restrictive cardiomyopathy (RCM) associated with an atrial septal defects (ASDs) and 1 with left ventricular non-compaction (LVNC; Rodriguez-Serrano 2014 PMID: 25201647, GeneDx pers. comm., LMM data). This variant segregated with DCM in 1 affected relative (LMM data) and with LVNC in 3 affected relatives from another family, 1 of whom had additional clinical features such as ASDs (Rodriguez-Serrano 2014 PMID: 25201647). This variant has also been reported by clinical laboratories in ClinVar (Variation ID 177886) and was absent from large population studies. Computational prediction tools and conservation analysis suggest that the p.Ile289Thr are consistent with pathogenicity. In summary, although additional studies are required to fully establish its clinical significance, the p.Ile289Thr variant is likely pathogenic for autosomal dominant cardiomyopathy, particularly DCM and LVNC. ACMG/AMP criteria applied: PS4_Supporting, PP1_Moderate, PM2, PP3. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at